Xu Zhou | Genetic Epidemiology | Best Researcher Award

Posted on 12/12/202412/12/2024 by PencisLeave a Comment

Dr. Xu Zhou | Genetic Epidemiology | Best Researcher Award

Hunan Provincial Materinal and Child Health Care Hospital | China

Author Profile

BIOGRAPHY OF XU ZHOU: DEDICATED RESIDENT PHYSICIAN IN PUBLIC HEALTH 🩺🌟

EARLY ACADEMIC PURSUITS 📚🎓

Xu Zhou, born in April 1991 in China, demonstrated an early commitment to advancing public health. Pursuing higher education with a Master’s degree in Public Health, he equipped himself with a solid foundation in health sciences. His academic endeavors at the master's level emphasized population health, disease prevention, and maternal and child care, preparing him for a meaningful career in healthcare.

PROFESSIONAL ENDEAVORS 🏥🔬

Currently serving as a Resident Physician at the prestigious Hunan Provincial Maternal and Child Health Care Hospital, Xu Zhou plays a vital role in improving the healthcare outcomes of mothers and children. His professional journey is marked by dedicated clinical practice and adherence to the highest standards of patient care. Working in a hospital recognized for excellence in maternal and child health, Xu Zhou contributes to the advancement of community health and clinical services.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC EPIDEMIOLOGY💡📖

Xu Zhou's contributions are centered on the intersection of clinical practice and public health research. His focus includes:

Enhancing healthcare systems for maternal and child health.
Promoting preventive measures to reduce mortality rates among vulnerable populations.
Exploring innovative strategies for improving overall public health outcomes in Hunan Province.

IMPACT AND INFLUENCE 🌍💪

Through his work as a resident physician, Xu Zhou impacts countless lives, providing essential medical services to mothers and children in need. His dedication has bolstered the healthcare infrastructure of the community he serves. As a professional in public health, he inspires colleagues to uphold the ethos of patient-centric care.

ACADEMIC CITATIONS AND SCHOLARLY CONTRIBUTIONS 📑✨

Though primarily focused on clinical work, Xu Zhou actively contributes to the field of public health through knowledge dissemination. His insights are integral to hospital workshops and training programs, fostering a culture of learning and skill development among healthcare professionals.

LEGACY AND FUTURE CONTRIBUTIONS 🚀🌟

Xu Zhou aspires to leave a lasting legacy as a compassionate physician and an advocate for maternal and child health. His future contributions are aimed at:

Innovating clinical practices to enhance maternal and child health outcomes.
Expanding his research portfolio to include broader public health challenges.
Mentoring young healthcare professionals to build a stronger healthcare workforce.

NOTABLE PUBLICATIONS 📑

"Fetal deaths from birth defects in Hunan Province, China, 2016–2020"

Authors: Zhou, X. , He, J. , Wang, A. , Jiang, Y. , Shi, Y.
Journal: Scientific Reports
Year: 2024

"Prevalence and death rate of birth defects from population-based surveillance in Hunan Province, China, 2010–2020"

Authors: Zhou, X. , Xie, D. , Jiang, Y. , Fang, J.
Journal: Scientific Reports
Year: 2024

"Risk factors for maternal near-miss in an undeveloped province in south-central China, 2012–2022"

Authors: Zhou, X. , Fang, J. , Wu, Y. , Wang, A. , Shu, C.
Journal: BMC Public Health
Year: 2024

"Multivariate logistic regression analysis of risk factors for birth defects: a study from population-based surveillance data"

Authors: Zhou, X. , He, J. , Wang, A. , Shu, C. , Fang, J.
Journal: BMC Public Health
Year: 2024

"Epidemiology of congenital polydactyly and syndactyly in Hunan Province, China"

Authors: Zhou, X. , Li, T. , Kuang, H. , Fang, J. , Wang, H.
Journal: BMC Pregnancy and Childbirth
Year: 2024

Yongqing Dong | Genetic Diseases | Best Researcher Award

Posted on 30/11/202409/12/2024 by PencisLeave a Comment

Assoc. Prof. Dr. Yongqing Dong | Genetic Diseases | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid ID

📖 BIOGRAPHY OF YONGQING DONG

🎓 EARLY ACADEMIC PURSUITS

Yongqing Dong’s academic journey began with a focus on social development and public policy, eventually expanding into interdisciplinary fields like labor migration, child development, and health care. His commitment to understanding social dynamics in rural and urban China has laid the groundwork for his distinguished career.

💼 PROFESSIONAL ENDEAVORS

2023–Present: Associate Professor, College of Management and Economics, Tianjin University
2018–2023: Assistant Professor, College of Management and Economics, Tianjin University

Dong has cultivated an academic environment that merges policy analysis with real-world applications, fostering innovation and practical solutions to societal challenges.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC DISEASES

Yongqing Dong's research investigates pressing social issues, such as the effects of labor migration on children’s development and healthcare accessibility. His research areas include:

Primary Focus: Social development and public policy
Secondary Focus:
- Labor migration and its societal impacts
- Child development in rural and urban settings
- Innovations in healthcare systems

His landmark study, "The Long-Term Effect of Parental Migration on the Human Capital Accumulation of Children: Evidence from Rural China," supported by the Humanity and Social Science Youth Foundation of the Ministry of Education of China, underscores his dedication to advancing public knowledge.

🌍 IMPACT AND INFLUENCE

Dong's insights into labor migration and its influence on family dynamics have shaped discussions among policymakers and scholars. His work on child development provides critical perspectives for improving education and healthcare systems, particularly in rural China.

📚 ACADEMIC CITATIONS

Yongqing Dong’s scholarship has been recognized in highly regarded journals, including:

Social Forces
China Economic Review
Journal of Family Studies
Economic Analysis and Policy

Additionally, he contributes as a referee to prominent journals, influencing academic discourse on economics and public health.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

As an active member of professional associations like the Agricultural & Applied Economics Association (China Section) and the Chinese Economist Society, Yongqing Dong is at the forefront of economic and policy research. His future endeavors will likely further explore how social policies can mitigate inequalities and foster development in underprivileged regions.

Through teaching, mentorship, and groundbreaking research, Dong is shaping the next generation of policymakers and scholars.

🗣️ LANGUAGES

English: Professional working proficiency
Mandarin: Native

This biography celebrates Yongqing Dong's commitment to addressing the complexities of societal development through rigorous research and impactful teaching. 🌟

📑 NOTABLE PUBLICATIONS

"The Divergence of Inequality in Healthcare Utilization Between Poor- and Rich-Medical Resource Regions: Evidence from the Middle-Aged and Older Adults in China"

Authors: Fang, Y. , Fu, L. , Xu, Y. , Dong, Y.
Journal: Social Indicators Research
Year: 2024

"Mediating Effects of Information Access on Internet Use and Multidimensional Health Among Middle-Aged and Older Adults: Nationwide Cross-Sectional Study"

Authors: Fu, L. , Liu, C. , Dong, Y. , Li, D. , Di, K.
Journal: Journal of Medical Internet Research
Year: 2024

"How does information and communication technology promote tourism development? Evidence from the e-commerce pilot city policy in China"

Authors: Fu, L. , Yang, J. , Dong, Y. , Pei, T.
Journal: Tourism Economics
Year: 2024

"The healthcare inequality among middle-aged and older adults in China: a comparative analysis between the full samples and the homogeneous population"

Authors: Fu, L. , Fang, Y. , Dong, Y.
Journal: Health Economics Review
Year: 2022

"The Health Inequality of Children in China: A Regression-Based Decomposition Analysis"

Authors: Dong, Y. , Deng, Q. , Li, S.
Journal: Child Indicators Research
Year: 2022

Bayasgaslan Gombojav | Lipid Genetics | Best Faculty Award

Posted on 30/11/202411/12/2024 by PencisLeave a Comment

Dr. Bayasgaslan Gombojav | Lipid Genetics | Best Faculty Award

Mongolian National University of Medical Sciences | Mongolia

Author Profile

Scopus

🌟 BAYASGALAN GOMBOJAV, MD, MPH, PHD

Lecturer in Biostatistics
Department of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences

🎓 EARLY ACADEMIC PURSUITS

Dr. Bayasgalan Gombojav began his academic journey with an M.D. from the National Medical University of Mongolia in 1998, where he cultivated a solid foundation in medicine. His pursuit of excellence led him to specialize in public health, earning an M.P.H. (2004) and Ph.D. (2009) from Yonsei University, South Korea, one of Asia’s leading institutions. His doctoral research focused on epidemiology, biostatistics, and health promotion, equipping him with robust expertise in public health and genomics.

To expand his medical expertise, he completed a pediatric residency (2016-2018) and a subspecialty course in Pediatric Pulmonology (2018-2019) at the Mongolian National University of Medical Sciences.

💼 PROFESSIONAL ENDEAVORS

Dr. Gombojav has an extensive career spanning diverse roles in academia, research, and healthcare:

Academic Roles

Lecturer in Epidemiology and Biostatistics (2019–Present)
Mongolian National University of Medical Sciences
- Focuses on epidemiological methodologies, biostatistical modeling, and public health systems.
Lecturer in Epidemiology (1998–2001)
National Medical University of Mongolia
- Contributed to shaping the next generation of Mongolian public health professionals.

Research Experience

Dr. Gombojav has conducted advanced genomic and epidemiological research:

Postdoctoral Fellow & Researcher (2011–2016)
Seoul National University, Korea
- Worked on genomic medicine, complex disease epidemiology, and environment-health interactions.
Researcher (2010–2011)
Institute for Health Promotion, Yonsei University
- Investigated preventive strategies in public health under Dr. Heechoul Ohrr.
Researcher (2009–2010)
Hiroshima University, Japan
- Focused on infectious disease control and epidemiological modeling under Prof. Junko Tanaka.

Clinical Experience

Pediatrician (2019)
Mongolian-Japan Teaching Hospital
- Specialized in pediatric pulmonology and comprehensive child health care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON LIPID GENETICS

Dr. Gombojav has significantly contributed to the fields of public health, epidemiology, and pediatric care:

Genomic Epidemiology: His postdoctoral work at Seoul National University advanced the understanding of the genetic basis of complex diseases and their interaction with environmental factors.
Infectious Disease Control: His research at Hiroshima University addressed critical public health challenges in managing infectious diseases.
Pediatric Pulmonology: His clinical contributions improved care protocols for respiratory diseases in children.

🌍 IMPACT AND INFLUENCE

Dr. Gombojav’s work bridges the gap between molecular medicine, epidemiology, and public health:

Educational Influence: He has mentored numerous students, fostering a new generation of public health experts in Mongolia.
Global Collaboration: His international experience in Korea, Japan, and Mongolia underscores his role as a connector of global and local health initiatives.

📚 ACADEMIC CITATIONS

Dr. Gombojav has authored several peer-reviewed articles in the fields of genomics, epidemiology, and public health. His research has been cited extensively, reflecting the scientific community's recognition of his contributions.

🏅 AWARDS

Travel Award (2011): International Congress of Human Genetics, American Society of Human Genetics, Montreal, Canada.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Gombojav's legacy lies in his interdisciplinary approach to addressing public health challenges through genomic research and pediatric care. Looking forward:

He aims to further integrate genomics into public health practices in Mongolia.
He is committed to expanding public health education and fostering global partnerships to advance health outcomes.

🌟 HIGHLIGHTS

A distinguished academic and researcher in public health and biostatistics.
Prolific educator shaping the future of Mongolian healthcare.
Internationally recognized for contributions to genomic epidemiology and pediatric pulmonology.

📑 NOTABLE PUBLICATIONS

"Genetic Basis of Hearing Loss in Mongolian Patients: A Next-Generation Sequencing Study"

Authors: Gombojav, B. , Erdenechuluun, J. , Makhbal, Z. , Tsai, C.-Y. , Wu, C.-C
Journal: Genes
Year: 2024

"The CODATwins Project: The Current Status and Recent Findings of COllaborative Project of Development of Anthropometrical Measures in Twins"

Authors: Silventoinen, K. , Jelenkovic, A. , Yokoyama, Y. , Boomsma, D.I. , Kaprio, J.
Journal: Twin Research and Human Genetics
Year: 2019

"Birth size and gestational age in opposite-sex twins as compared to same-sex twins: An individual-based pooled analysis of 21 cohorts"

Authors: Jelenkovic, A. , Sund, R. , Yokoyama, Y. , Kaprio, J. , Silventoinen, K.
Journal: Scientific Reports
Year: 2018

"Genetic and environmental factors affecting birth size variation: A pooled individual-based analysis of secular trends and global geographical differences using 26 twin cohorts"

Authors: Yokoyama, Y. , Jelenkovic, A. , Hur, Y.-M. , Kaprio, J. , Silventoinen, K.
Journal: International Journal of Epidemiology
Year: 2018

"Associations between birth size and later height from infancy through adulthood: An individual based pooled analysis of 28 twin cohorts participating in the CODATwins project"

Authors: Jelenkovic, A. , Yokoyama, Y. , Sund, R. , Kaprio, J. , Silventoinen, K.
Journal: Early Human Development
Year: 2018

Bijina Balakrishnan | Molecular Basis of Genetic Disease | Best Researcher Award

Posted on 30/03/202430/03/2024 by PencisLeave a Comment

Dr. Bijina Balakrishnan | Molecular Basis of Genetic Disease | Best Researcher Award

University of Utah | United States

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Bijina Balakrishnan embarked on her academic journey in the field of biotechnology with a Bachelor of Science degree in Biology & Chemistry from the University of Calicut, Kerala, India, in 1999. She further pursued her passion for biotechnology by obtaining a Master of Science degree in Biotechnology from Cochin University of Science and Technology, Kerala, India, in 2002. Her dedication to advancing knowledge in the field led her to pursue a Doctor of Philosophy (PhD) in Biotechnology, which she successfully completed at Cochin University of Science and Technology, Kerala, India, in 2008.

PROFESSIONAL ENDEAVORS

Balakrishnan's professional journey has been characterized by a steadfast commitment to research excellence and innovation. She has held various significant positions in esteemed academic and research institutions, including:

RESEARCH SCIENTIST University of Utah, Salt Lake City (2021 - Present)

RESEARCH ASSOCIATE University of Utah, Salt Lake City (2019 - 2021)

POST-DOCTORAL FELLOW University of Utah, Salt Lake City (2014 - 2019)

POST-DOCTORAL FELLOW Nanyang Technological University, Singapore (2008)

SENIOR RESEARCH FELLOW Kannur University, India (2007 - 2008)

GRADUATE RESEARCHER Cochin University of Science and Technology, India (2003 - 2007)

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETICS DISEASE

Balakrishnan's contributions to the field of biotechnology are multifaceted and impactful, spanning from basic research to translational applications. Her research endeavors have primarily focused on rare metabolic disorders, with a particular emphasis on Galactosemia and dilated cardiomyopathy. Some notable contributions include:

Development and optimization of preclinical therapeutic interventions for Galactosemia and dilated cardiomyopathy.
Characterization of mouse models for Galactosemia and elucidation of disease mechanisms.
Design and execution of gene therapy strategies for cardiac-specific conditions.
Profiling small molecule modulators for novel therapeutic targets.
Investigation of cellular responses to viral proteins, such as the SARS-CoV-2 Spike protein, and evaluation of potential therapeutic interventions.

IMPACT AND INFLUENCE

Balakrishnan's work has made a significant impact on both the scientific community and the broader field of biotechnology. Her research findings have been presented at numerous conferences and workshops, contributing to the dissemination of knowledge and fostering collaboration among scientists. Additionally, her efforts have led to the development of novel therapeutic approaches for rare metabolic disorders, offering hope to patients and clinicians alike.

ACADEMIC CITATIONS

Balakrishnan's research contributions have been recognized through academic honors and awards, including the Best Researcher Award at the International Research Awards on Cardiology and Cardiovascular Medicine. Moreover, she has received prestigious grants and funding support from organizations such as the Galactosemia Foundation and the National Institutes of Health (NIH).

LEGACY AND FUTURE CONTRIBUTIONS

Balakrishnan's legacy in the field of biotechnology is characterized by her dedication to scientific inquiry, innovation, and translational research. As she continues her professional journey, she remains committed to advancing knowledge, developing novel therapeutic interventions, and mentoring the next generation of scientists. Her future contributions are poised to further shape the landscape of biotechnology and positively impact the lives of individuals affected by rare metabolic disorders.

NOTABLE PUBLICATIONS

Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia 2020(38)

Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors 2021(3)

AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG) 2023(3)

AAV9-based PMM2 gene replacement augments PMM2 expression and improves glycosylation in primary fibroblasts of patients with phosphomannomutase 2 deficiency (PMM2-CDG)

Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia